Nasal vaccine combats bird flu infection in rodents

Nasal vaccine combats bird flu infection in rodents

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to farm animals to humans. In rodents, the vaccine elicited a strong immune response and prevented infections in H5N1-exposed animals.
Stephanie Mazzucca-Ragan

Stephanie Mazzucca-Ragan

Stephanie Mazzucca-Ragan, an assistant professor at the WashU School of Public Health, is working to shape young people’s lives by developing ways to promote healthy eating and physical activity. Those behaviors can pay dividends from better learning to preventing chronic disease down the road.
Older Stories